Management ChangeJun 26, 2026, 04:33 PM
Ernexa Therapeutics SVP of Finance Resigns
AI Summary
Ernexa Therapeutics Inc. announced the resignation of Sandra Gurrola, its Senior Vice President of Finance, effective July 3, 2026. The company stated that her departure was not due to any disagreement regarding its operations, policies, or practices. Ms. Gurrola has agreed to provide part-time transition assistance until the filing of the company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2026. Ernexa Therapeutics has begun a search for a successor and plans to utilize external support for finance, accounting, and reporting matters in the interim.
Key Highlights
- Sandra Gurrola, Senior Vice President of Finance, resigned from Ernexa Therapeutics Inc.
- Her resignation is effective July 3, 2026.
- The resignation was not due to any disagreement with the company's operations or policies.
- Ms. Gurrola will provide part-time transition assistance until the Q2 2026 10-Q filing.
- Ernexa Therapeutics has initiated a search for a successor.
- The company will use outside support for finance, accounting, and reporting until a successor is appointed.
Price Impact
More from ERNA